Latest News in the pharma Industry
Market News
Alvotech and DKSH extend biosimilar partnership in Asia
22 Sep 2020
The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.
Read more
Europital launches as a science-driven full-service CRO
22 Sep 2020
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.
Read more
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis
22 Sep 2020
The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.
Read more
T-knife and Catalent sign tech transfer and manufacturing agreement
21 Sep 2020
Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.
Read more
Metrics Contract Services begins $10M plant expansion
21 Sep 2020
Clients set to benefit immediately through "higher yields" and "improved potent handling".
Read more
TESSA technology for robust and reproducible AAV manufacture at scale
21 Sep 2020
Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies.
Read more
Gilead Sciences agrees to buy Immunomedics in $21 billion deal
16 Sep 2020
Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer.
Read more
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
15 Sep 2020
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.
Read more
Univercells Technologies introduces new upstream platform for virus manufacturing
15 Sep 2020
The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing.
Read more
Mylan and development partner win significant EPO ruling related to Copaxone
15 Sep 2020
Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe.
Read more
Evotec and Bioaster partner to build technology and innovation hub in Lyon
14 Sep 2020
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.
Read more
Biogen invests $250 million to eliminate its use of fossil fuels
14 Sep 2020
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040.
Read more